Pharmaceutical Meaning-Making Beyond Marketing: Racialized Subjects of Generic Thiazide

Journal of Law, Medicine and Ethics 36 (3):530-536 (2008)
  Copy   BIBTEX

Abstract

In contrast to discussions of BiDil, this paper explores racial meaning-making processes around an old generic hypertension drug. By unpacking a vignette about race and thiazide outside marketing or medicine, it shows that racialization of drugs exceeds those spheres and moves in unpredictable ways

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 92,261

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Marketing ethics.George G. Brenkert - 2008 - Malden, MA: Blackwell.
Healthy children as subjects in pharmaceutical research.Gideon Koren - 2003 - Theoretical Medicine and Bioethics 24 (2):149-159.
Theodore Levitt's marketing myopia.Colin Grant - 1999 - Journal of Business Ethics 18 (4):397 - 406.
Is Marketing the Enemy of Pharmaceutical Innovation?Kalman Applbaum - 2009 - Hastings Center Report 39 (4):13-17.
A Framework for Assessing Immorally Manipulative Marketing Tactics.Shlomo Sher - 2011 - Journal of Business Ethics 102 (1):97-118.
Pharmaceutical medicine.D. M. Burley & Theodore Barker Binns (eds.) - 1985 - Baltimore, Md., U.S.A.: E. Arnold.

Analytics

Added to PP
2010-09-13

Downloads
37 (#433,623)

6 months
9 (#317,143)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations